Seeking Alpha

Pfizer (PFE) is acquiring Icagen (ICGN), a developer of pain relief drugs, for $6/share. After...

Pfizer (PFE) is acquiring Icagen (ICGN), a developer of pain relief drugs, for $6/share. After accounting for Pfizer's current 11% stake in the company, the transaction will cost approximately $49.8M. Icagen, which closed yesterday at $7.75, is down 23.2% on the news. One legal firm is already announcing an investigation into the deal.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector